North America Pharma 4.0 Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Technology, By Country and Growth Forecast, 2024

List of Tables

The North America Pharma 4.0 Market would witness market growth of 18.0% CAGR during the forecast period (2024-2031).

The US market dominated the North America Pharma 4.0 Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $10,599.3 million by 2031. The Canada market is experiencing a CAGR of 20.5% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 19.5% during (2024 - 2031).

The core idea of this 4.0 is to create a smart, flexible, and agile production environment where real-time data is continuously gathered and analyzed across every stage of the pharmaceutical lifecycle-from research and drug discovery to production, quality control, and distribution. This enables pharmaceutical companies to make better decisions, optimize production processes, and reduce human error, ultimately leading to faster drug development, higher product quality, and improved regulatory compliance.

This 4.0 is timely, given the rising demand for faster drug development, personalized medicine, and more efficient production processes. Traditional pharmaceutical manufacturing methods, which often involve manual processes and significant human intervention, are no longer sufficient to meet the complex challenges of modern healthcare.

The demand for this 4.0 technologies is rapidly increasing across North America, driven by the region's advanced pharmaceutical industry and growing focus on digital transformation. Governments and pharmaceutical companies are embracing Industry 4.0 technologies such as AI, IoT, and big data to enhance manufacturing, drug discovery, and patient care. The increasing demand for this 4.0 is fueled significantly by strong government initiatives to modernize the pharmaceutical industry in the United States. Thus, the overall landscape in North America reflects a growing commitment to leveraging Pharma 4.0 to improve operational efficiency and patient outcomes.

Based on Type, the market is segmented into Software and Services. Based on Application, the market is segmented into Drug Discovery & Development, Manufacturing, Supply Chain Management, and Other Application. Based on End Use, the market is segmented into Pharma & Biotech companies, CRO & CDMO, and Healthcare Providers. Based on Technology, the market is segmented into AI & ML, Big Data Analytics, IoT, Blockchain Technology, and Other Technology. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Amazon Web Services, Inc.
SAP SE
Oracle Corporation
Microsoft Corporation
IBM Corporation
GE HealthCare Technologies, Inc.
Siemens Healthineers AG (Siemens AG)
Cisco Systems, Inc.
Dassault Systemes SE
UnitedHealth Group, Inc. (Optum, Inc.)

North America Pharma 4.0 Market Report Segmentation

By Type

Software
Services

By Application

Drug Discovery & Development
Manufacturing
Supply Chain Management
Other Application

By End Use

Pharma & Biotech companies
CRO & CDMO
Healthcare Providers

By Technology

AI & ML
Big Data Analytics
IoT
Blockchain Technology
Other Technology

By Country

US
Canada
Mexico
Rest of North America

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Pharma 4.0 Market, by Type
- 1.4.2 North America Pharma 4.0 Market, by Application
- 1.4.3 North America Pharma 4.0 Market, by End Use
- 1.4.4 North America Pharma 4.0 Market, by Technology
- 1.4.5 North America Pharma 4.0 Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2023, May - 2024, Sep) Leading Players
4.5 Porter Five Forces Analysis

Chapter 5. North America Pharma 4.0 Market by Type

5.1 North America Software Market by Region
5.2 North America Services Market by Region

Chapter 6. North America Pharma 4.0 Market by Application

6.1 North America Drug Discovery & Development Market by Country
6.2 North America Manufacturing Market by Country
6.3 North America Supply Chain Management Market by Country
6.4 North America Other Application Market by Country

Chapter 7. North America Pharma 4.0 Market by End Use

7.1 North America Pharma & Biotech companies Market by Country
7.2 North America CRO & CDMO Market by Country
7.3 North America Healthcare Providers Market by Country

Chapter 8. North America Pharma 4.0 Market by Technology

8.1 North America AI & ML Market by Country
8.2 North America Big Data Analytics Market by Country
8.3 North America IoT Market by Country
8.4 North America Blockchain Technology Market by Country
8.5 North America Other Technology Market by Country

Chapter 9. North America Pharma 4.0 Market by Country

9.1 US Pharma 4.0 Market
- 9.1.1 US Pharma 4.0 Market by Type
- 9.1.2 US Pharma 4.0 Market by Application
- 9.1.3 US Pharma 4.0 Market by End Use
- 9.1.4 US Pharma 4.0 Market by Technology
9.2 Canada Pharma 4.0 Market
- 9.2.1 Canada Pharma 4.0 Market by Type
- 9.2.2 Canada Pharma 4.0 Market by Application
- 9.2.3 Canada Pharma 4.0 Market by End Use
- 9.2.4 Canada Pharma 4.0 Market by Technology
9.3 Mexico Pharma 4.0 Market
- 9.3.1 Mexico Pharma 4.0 Market by Type
- 9.3.2 Mexico Pharma 4.0 Market by Application
- 9.3.3 Mexico Pharma 4.0 Market by End Use
- 9.3.4 Mexico Pharma 4.0 Market by Technology
9.4 Rest of North America Pharma 4.0 Market
- 9.4.1 Rest of North America Pharma 4.0 Market by Type
- 9.4.2 Rest of North America Pharma 4.0 Market by Application
- 9.4.3 Rest of North America Pharma 4.0 Market by End Use
- 9.4.4 Rest of North America Pharma 4.0 Market by Technology

Chapter 10. Company Profiles

10.1 Amazon Web Services, Inc. (Amazon.com, Inc.)
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental Analysis
- 10.1.4 Recent strategies and developments:
  - 10.1.4.1 Partnerships, Collaborations, and Agreements:
- 10.1.5 SWOT Analysis
10.2 Oracle Corporation
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
  - 10.2.5.1 Partnerships, Collaborations, and Agreements:
  - 10.2.5.2 Acquisition and Mergers:
- 10.2.6 SWOT Analysis
10.3 Microsoft Corporation
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expenses
- 10.3.5 Recent strategies and developments:
  - 10.3.5.1 Product Launches and Product Expansions:
- 10.3.6 SWOT Analysis
10.4 IBM Corporation
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Regional & Segmental Analysis
- 10.4.4 Research & Development Expenses
- 10.4.5 Recent strategies and developments:
  - 10.4.5.1 Partnerships, Collaborations, and Agreements:
  - 10.4.5.2 Acquisition and Mergers:
- 10.4.6 SWOT Analysis
10.5 SAP SE
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Regional Analysis
- 10.5.4 Research & Development Expense
- 10.5.5 Recent strategies and developments:
  - 10.5.5.1 Partnerships, Collaborations, and Agreements:
  - 10.5.5.2 Acquisition and Mergers:
- 10.5.6 SWOT Analysis
10.6 GE HealthCare Technologies, Inc.
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Segmental and Regional Analysis
- 10.6.4 Research & Development Expenses
- 10.6.5 Recent strategies and developments:
  - 10.6.5.1 Product Launches and Product Expansions:
- 10.6.6 SWOT Analysis
10.7 Siemens Healthineers AG (Siemens AG)
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental and Regional Analysis
- 10.7.4 Research & Development Expense
- 10.7.5 Recent strategies and developments:
  - 10.7.5.1 Partnerships, Collaborations, and Agreements:
- 10.7.6 SWOT Analysis
10.8 Cisco Systems, Inc.
- 10.8.1 Company Overview
- 10.8.2 Financial Analysis
- 10.8.3 Regional Analysis
- 10.8.4 Research & Development Expense
- 10.8.5 Recent strategies and developments:
  - 10.8.5.1 Partnerships, Collaborations, and Agreements:
- 10.8.6 SWOT Analysis
10.9 Dassault Systemes SE
- 10.9.1 Company Overview
- 10.9.2 Financial Analysis
- 10.9.3 Regional Analysis
- 10.9.4 Research & Development Expense
- 10.9.5 Recent strategies and developments:
  - 10.9.5.1 Partnerships, Collaborations, and Agreements:
- 10.9.6 SWOT Analysis
10.10. UnitedHealth Group, Inc. (Optum, Inc.)
- 10.10.1 Company Overview
- 10.10.2 Financial Analysis
- 10.10.3 Segmental Analysis

LIST OF TABLES

TABLE 1 North America Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 2 North America Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Pharma 4.0 Market
TABLE 4 Product Launches And Product Expansions- Pharma 4.0 Market
TABLE 5 Acquisition and Mergers- Pharma 4.0 Market
TABLE 6 North America Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 7 North America Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 8 North America Software Market by Region, 2020 - 2023, USD Million
TABLE 9 North America Software Market by Region, 2024 - 2031, USD Million
TABLE 10 North America Services Market by Region, 2020 - 2023, USD Million
TABLE 11 North America Services Market by Region, 2024 - 2031, USD Million
TABLE 12 North America Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 13 North America Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 14 North America Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 15 North America Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 16 North America Manufacturing Market by Country, 2020 - 2023, USD Million
TABLE 17 North America Manufacturing Market by Country, 2024 - 2031, USD Million
TABLE 18 North America Supply Chain Management Market by Country, 2020 - 2023, USD Million
TABLE 19 North America Supply Chain Management Market by Country, 2024 - 2031, USD Million
TABLE 20 North America Other Application Market by Country, 2020 - 2023, USD Million
TABLE 21 North America Other Application Market by Country, 2024 - 2031, USD Million
TABLE 22 North America Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 23 North America Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 24 North America Pharma & Biotech companies Market by Country, 2020 - 2023, USD Million
TABLE 25 North America Pharma & Biotech companies Market by Country, 2024 - 2031, USD Million
TABLE 26 North America CRO & CDMO Market by Country, 2020 - 2023, USD Million
TABLE 27 North America CRO & CDMO Market by Country, 2024 - 2031, USD Million
TABLE 28 North America Healthcare Providers Market by Country, 2020 - 2023, USD Million
TABLE 29 North America Healthcare Providers Market by Country, 2024 - 2031, USD Million
TABLE 30 North America Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 31 North America Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 32 North America AI & ML Market by Country, 2020 - 2023, USD Million
TABLE 33 North America AI & ML Market by Country, 2024 - 2031, USD Million
TABLE 34 North America Big Data Analytics Market by Country, 2020 - 2023, USD Million
TABLE 35 North America Big Data Analytics Market by Country, 2024 - 2031, USD Million
TABLE 36 North America IoT Market by Country, 2020 - 2023, USD Million
TABLE 37 North America IoT Market by Country, 2024 - 2031, USD Million
TABLE 38 North America Blockchain Technology Market by Country, 2020 - 2023, USD Million
TABLE 39 North America Blockchain Technology Market by Country, 2024 - 2031, USD Million
TABLE 40 North America Other Technology Market by Country, 2020 - 2023, USD Million
TABLE 41 North America Other Technology Market by Country, 2024 - 2031, USD Million
TABLE 42 North America Pharma 4.0 Market by Country, 2020 - 2023, USD Million
TABLE 43 North America Pharma 4.0 Market by Country, 2024 - 2031, USD Million
TABLE 44 US Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 45 US Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 46 US Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 47 US Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 48 US Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 49 US Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 50 US Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 51 US Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 52 US Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 53 US Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 54 Canada Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 55 Canada Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 56 Canada Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 57 Canada Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 58 Canada Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 59 Canada Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 60 Canada Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 61 Canada Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 62 Canada Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 63 Canada Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 64 Mexico Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 65 Mexico Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 66 Mexico Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 67 Mexico Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 68 Mexico Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 69 Mexico Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 70 Mexico Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 71 Mexico Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 72 Mexico Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 73 Mexico Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 74 Rest of North America Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 75 Rest of North America Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 76 Rest of North America Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 77 Rest of North America Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 78 Rest of North America Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 79 Rest of North America Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 80 Rest of North America Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 81 Rest of North America Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 82 Rest of North America Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 83 Rest of North America Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 84 Key Information - Amazon Web Services, Inc.
TABLE 85 Key Information - Oracle Corporation
TABLE 86 Key Information - Microsoft Corporation
TABLE 87 Key Information - IBM Corporation
TABLE 88 Key Information - SAP SE
TABLE 89 Key Information - GE HealthCare Technologies, Inc.
TABLE 90 Key Information - Siemens Healthineers AG
TABLE 91 Key Information - Cisco Systems, Inc.
TABLE 92 Key Information - Dassault Systemes SE
TABLE 93 Key Information - UnitedHealth Group, Inc.

North America Pharma 4.0 Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Technology, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents